The landscape of dementia diagnosis has progressed dramatically with the appearance of subtle biomarkers, including amyloid PET scans, tau imaging, and blood-centered assessments that could detect Alzheimer's pathology a long time prior to signs and symptoms arise. Even though these technological improvements signify remarkable development in knowing neurodegenerative illnesses, they https://norwichn530kud9.wikipublicist.com/user